Hem › Multipelt myelom › Michigan › Ann Arbor
Kliniska studier för Multipelt myelom i Ann Arbor, MI
10 studier för Multipelt myelom söker deltagare vid platser i och runt Ann Arbor (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
RekryterarFas 2
- University of Michigan Health System, Ann Arbor
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RekryterarFas 3
- University of Michigan, Ann Arbor
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekryterarFas 2
- Trinity Health Ann Arbor Hospital, Ann Arbor
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
RekryterarFas 1/2
- University of Michigan Health System - Ann Arbor /ID# 271536, Ann Arbor
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
RekryterarFas 1/2
- Research Site, Ann Arbor
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
RekryterarFas 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi bort
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi bort
- och 4 fler
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
RekryterarFas 1/2
- Research Site, Ann Arbor
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
RekryterarFas 4
- University of Michigan, Ann Arbor
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RekryterarFas 3
- Saint Joseph Mercy Hospital, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi bort
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi bort
- och 4 fler
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
RekryterarFas 3
- GSK Investigational Site, Ann Arbor
Multipelt myelom-studier i andra städer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andra studier i Ann Arbor
- Prostatacancer27 studier
- Bröstcancer26 studier
- Icke-småcellig lungcancer26 studier
- Cancer (alla typer)25 studier
- Kolorektal cancer23 studier
- Lungcancer23 studier
- Hjärtsvikt22 studier
- Akut myeloid leukemi17 studier
- Hjärt-kärlsjukdom16 studier
- Bukspottkörtelcancer14 studier
- Melanom12 studier
- Njurcancer (renalcelskarcinom)12 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.